84 related articles for article (PubMed ID: 11429580)
41. Expression and amplification of Her2, EGFR and cyclin D1 in breast cancer: immunohistochemistry and chromogenic in situ hybridization.
Cho EY; Choi YL; Han JJ; Kim KM; Oh YL
Pathol Int; 2008 Jan; 58(1):17-25. PubMed ID: 18067636
[TBL] [Abstract][Full Text] [Related]
42. MMTV promoter hypomethylation is linked to spontaneous and MNU associated c-neu expression and mammary carcinogenesis in MMTV c-neu transgenic mice.
Zhou H; Chen WD; Qin X; Lee K; Liu L; Markowitz SD; Gerson SL
Oncogene; 2001 Sep; 20(42):6009-17. PubMed ID: 11593408
[TBL] [Abstract][Full Text] [Related]
43. Chromosome alterations in rat mammary tumor progression.
Aldaz CM; Gollahon LS; Chen A
Prog Clin Biol Res; 1992; 376():137-53. PubMed ID: 1528918
[No Abstract] [Full Text] [Related]
44. The genetic pathology of breast cancer.
Callahan R; Cropp C; Gallahan D; Liscia D; Merlo G; Smith GH; Lidereau R
Prog Clin Biol Res; 1992; 376():117-36. PubMed ID: 1528917
[No Abstract] [Full Text] [Related]
45. Identification of oncogenes in breast tumors and their effects on growth and differentiation.
Groner B; Hynes NE; Kozma S; Redmond S; Saurer S; Schmitt-Ney M; Ball R; Reichmann E; Shöenberger C; Andres AC
Cancer Treat Res; 1988; 40():67-92. PubMed ID: 2908662
[No Abstract] [Full Text] [Related]
46. Lethal breast cancer.
O'Shaughnessy JA
Clin Breast Cancer; 2010; 10 Suppl 1():E6-7. PubMed ID: 20587408
[No Abstract] [Full Text] [Related]
47. Genetically engineered rat models for breast cancer.
Smits BM; Cotroneo MS; Haag JD; Gould MN
Breast Dis; 2007; 28():53-61. PubMed ID: 18057543
[TBL] [Abstract][Full Text] [Related]
48. The role of ras gene expression and transforming growth factor alpha production in the etiology and progression of rodent and human breast cancer.
Salomon DS; Ciardiello F; Valverius EM; Kim N
Cancer Treat Res; 1991; 53():107-57. PubMed ID: 1672074
[No Abstract] [Full Text] [Related]
49. Cancer of the breast--a Darwinian disease.
Ogardus GM
Am Surg; 1968 Jul; 34(7):528-9. PubMed ID: 5690170
[No Abstract] [Full Text] [Related]
50. Mouse modifier genes in mammary tumorigenesis and metastasis.
Winter SF; Hunter KW
J Mammary Gland Biol Neoplasia; 2008 Sep; 13(3):337-42. PubMed ID: 18661105
[TBL] [Abstract][Full Text] [Related]
51. Potential specific breast cancer treatment uncovered in mouse experiments.
Bradbury J
Lancet; 2001 Jun; 357(9274):2109. PubMed ID: 11445115
[No Abstract] [Full Text] [Related]
52. RNA interference, DNA methylation, and gene silencing: a bright future for cancer therapy?
Swanton C; Nicke B; Downward J
Lancet Oncol; 2004 Nov; 5(11):653-4. PubMed ID: 15522650
[No Abstract] [Full Text] [Related]
53. [Studies on the influence of genetic factors in the development of cancer of the lacteal glands in mice].
Dux A; Mühlbock O
Jaarb Kankeronderz Kankerbestrijd Ned; 1964; 14():253-7. PubMed ID: 5846453
[No Abstract] [Full Text] [Related]
54. Epidermal growth factor receptor: a transcription factor?
Wong RW; Chan SY
Trends Biochem Sci; 2001 Nov; 26(11):645-6. PubMed ID: 11701312
[No Abstract] [Full Text] [Related]
55. Radionuclide-peptide nucleic acid in diagnosis and treatment of pancreatic cancer.
Wickstrom E; Tian X; Amirkhanov NV; Chakrabarti A; Aruva MR; Rao PS; Qin W; Zhu W; Sauter ER; Thakur ML
Methods Mol Med; 2005; 106():135-91. PubMed ID: 15375316
[No Abstract] [Full Text] [Related]
56. Rats: gnawing through the barriers to understanding genetic susceptibility and breast cancer.
Blackburn AC
Breast Cancer Res; 2011 Oct; 13(5):112. PubMed ID: 21999210
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of p21ras in human breast cancer.
Dati C; Catozzi L; Faggioli L; Giovannini G; Giai M; Sismondi P; Piffanelli A; De Bortoli M
Int J Biol Markers; 1988; 3(1):66. PubMed ID: 3074133
[No Abstract] [Full Text] [Related]
58. Relative paradigms between autoantibodies in lupus and autoantibodies in cancer.
Tan EM; Shi FD
Clin Exp Immunol; 2003 Nov; 134(2):169-77. PubMed ID: 14616773
[No Abstract] [Full Text] [Related]
59. Are all cancer genes equal?
Bartek J; Lukas J
Nature; 2001 Jun; 411(6841):1001-2. PubMed ID: 11429580
[No Abstract] [Full Text] [Related]
60. Specific protection against breast cancers by cyclin D1 ablation.
Yu Q; Geng Y; Sicinski P
Nature; 2001 Jun; 411(6841):1017-21. PubMed ID: 11429595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
